Effect of Sufi Music on Sleep, Cardiac Symptoms and Vital Signs in Open-Heart Surgery Patients
NCT07925606, Not applicable, Not yet recruiting, Yeliz Ciğerci
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effect of Sufi Music on Sleep, Cardiac Symptoms and Vital Signs in Open-Heart Surgery Patients | ClinicalTrials.gov |
| NCT number | NCT07925606 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 90 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Yeliz Ciğerci | ClinicalTrials.gov |
| Conditions | Sleep, Cardiac Symptoms, Vital Signs | ClinicalTrials.gov |
| Interventions | Sufi music, Placebo | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Richards-Campbell Sleep Questionnaire | Befor surgery (preoperative) and the morning following the intervention night (between 08:00 and 09:00) | This questionnaire was developed by Richards (1987) to assess the sleep quality of patients in intensive care and clinical settings \[28\], and its Turkish validity and reliability study was conducted by Özlü and Özer (2015) \[29\]. The questionnaire consists of six items and is scored on a scale of 0 to 100. However, the sixth item, which measures external stimuli/environmental factors (noise level), is not included in the calculation of the total score. The overall sleep quality score is calculated by dividing the sum of the scores obtained from the first five items by the number of items. The minimum score that can be obtained from the questionnaire is 0 and the maximum is 100. Higher scores indicate better sleep quality. In the evaluation, a score range of "0-25" represents very poor sleep quality, whereas a range of "76-100" represents very good sleep quality. The internal consistency | ClinicalTrials.gov |
| Secondary | Cardiac Symptom Survey | Befor surgery (preoperative) and the morning following the intervention night (between 08:00 and 09:00) | The scale developed by Nieveen et al. (2008) \[32\] was adapted into Turkish, with validity and reliability analyses conducted by Özkan and Taştan (2016) \[33\]. The scale covers a total of 10 core cardiac symptoms: chest pain, shortness of breath, fatigue, feeling sad, sleep problems, pain at the surgical site, leg swelling, palpitations, anxiety and loss of appetite. The scale is structurally composed of three main dimensions, namely "symptom perception", "symptom appraisal" and "response to symptoms", and assessments are made on a Likert-type scale scored from 0 to 10. A score of "0" indicates that the symptom is absent or does not affect the patient, whereas "10" represents the highest negative impact of the symptom on the patient. In the appraisal dimension, the mean of the frequency and severity of each symptom is calculated, whereas in the response dimension, the degree to which symptoms limit phy | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)